NCT07613723
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07613723
Title A Study to Test the Safety, Tolerability and Effect of ZI-MA4-1 for Patients With Locally Advanced or Metastatic Solid Malignancies
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Zelluna Immunotherapy AS
Indications
Therapies
Age Groups: adult | senior
Covered Countries GBR

Facility Status City State Zip Country Details
The Royal Marsden NHS Foundation Trust NOT_YET_RECRUITING London United Kingdom Details
The Christie NHS Foundation Trust RECRUITING Manchester United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field